KakehiSTompkinsDM.A review of pharmacologic neurostimulant use during rehabilitation and recovery after brain injury. Ann Pharmacother. 2021;55:1254-1266.
2.
SchneiderWNDrew-CatesJWongTMDombovyML.Cognitive and behavioral efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo- controlled study. Brain Inj. 1999;13:863-872. doi:10.1080 /026990599121061.
3.
MeythalerJMBrunnerRCJohnsonANovackTA.Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. J Head Trauma Rehabil. 2002;17:300-313. doi:10.1097/00001199-200208000-00004.
4.
SaniovaBDrobnyMKneslovaLMinarikM.The outcome of patients with severe head injuries treated with amantadine sulphate. J Neural Transm (Vienna). 2004;111:511-514. doi:10.1177/0018578720920803.
5.
KrausMFSmithGSButtersM, et al. Effects of the dopaminergic agent and NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: a study using positron emission tomography (PET). Brain Inj. 2005;19:471-479. doi:10.1080/02699050400025059.
6.
GiacinoJTWhyteJBagiellaE, et al. Placebo-controlled trial of amantadine for severe traumatic brain injury. N Engl J Med. 2012;366:819-826. doi:10.1056/NEJMoa1102609.
7.
GhalaenoviHFattahiAKoohpayehzadehJ, et al. The effects of amantadine on traumatic brain injury outcome: a double-blind, randomized, controlled, clinical trial. Brain Inj. 2018;32:1050-1055. doi:10.1080/02699052.2018.1476733.
8.
GagnonDJLeclercAMRikerRR, et al. Amantadine and modafinil as neurostimulants during post-stroke care: a systematic review. Neurocrit Care. 2020;33:283-297. doi:10.1007/s12028-020-00977-5.
9.
LeclercAMRikerRRBrownCS, et al. Amantadine and modafinil as neurostimulants following acute stroke: a retrospective study of intensive care unit patients. Neurocrit Care. 2021;34:102-111.
